CD8α(+) dendritic cells (DCs) prime cytotoxic T lymphocytes during viral infections and produce interleukin-12 in response to pathogens. Although the loss of CD8α(+) DCs in Batf3(-/-) mice increases their susceptibility to several pathogens, we observed that Batf3(-/-) mice exhibited enhanced resistance to the intracellular bacterium Listeria monocytogenes. In wild-type mice, Listeria organisms, initially located in the splenic marginal zone, migrated to the periarteriolar lymphoid sheath (PALS) where they grew exponentially and induced widespread lymphocyte apoptosis. In Batf3(-/-) mice, however, Listeria organisms remain trapped in the marginal zone, failed to traffic into the PALS, and were rapidly cleared by phagocytes. In addition, Batf3(-/-) mice, which lacked the normal population of hepatic CD103(+) peripheral DCs, also showed protection from liver infection. These results suggest that Batf3-dependent CD8α(+) and CD103(+) DCs provide initial cellular entry points within the reticuloendothelial system by which Listeria establishes productive infection.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3172670PMC
http://dx.doi.org/10.1016/j.immuni.2011.06.012DOI Listing

Publication Analysis

Top Keywords

batf3-/- mice
16
cd8α+ dendritic
8
dendritic cells
8
cellular entry
8
productive infection
8
listeria monocytogenes
8
mice listeria
8
listeria organisms
8
marginal zone
8
listeria
5

Similar Publications

Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of unresectable hepatocellular carcinoma (HCC), but their impressive efficacy is seen in just a fraction of patients. One key mechanism of immunotherapy resistance is the paucity of dendritic cells (DCs) in liver malignancies. Here, we tested combination blockade of programmed death receptor 1 (PD1) and CXCR4, a receptor for CXCL12, a pleiotropic factor that mediates immunosuppression in tumors.

View Article and Find Full Text PDF

Oral reovirus reshapes the gut microbiome and enhances antitumor immunity in colon cancer.

Nat Commun

October 2024

Medical Oncology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Seongnam, Gyeonggi-do, Republic of Korea.

Article Synopsis
  • - The study explores the use of an oncolytic reovirus (RC402) administered orally to stimulate antitumor immunity in advanced cancers, showing no major side effects while effectively reducing tumor lesions.
  • - The orally delivered reovirus interacts with the immune system, enhancing antibody production, reshaping the gut microbiome, and promoting immune activation, though it doesn't directly infect tumors outside the gastrointestinal tract.
  • - Combining oral reovirus treatment with immune checkpoint inhibitors (like αPD-1 and αCTLA-4) significantly enhances tumor regression and establishes lasting immune memory, highlighting its potential as an effective immunotherapy approach in cancer treatment.
View Article and Find Full Text PDF

Dendritic cells are crucial for bridging innate and adaptive immunity. Cryptococcosis, caused by and , is responsible for >15% of AIDS-related deaths. A recent study by Xu et al.

View Article and Find Full Text PDF

In vivo dendritic cell reprogramming for cancer immunotherapy.

Science

October 2024

Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, 221 84 Lund, Sweden.

Immunotherapy can lead to long-term survival for some cancer patients, yet generalized success has been hampered by insufficient antigen presentation and exclusion of immunogenic cells from the tumor microenvironment. Here, we developed an approach to reprogram tumor cells in vivo by adenoviral delivery of the transcription factors PU.1, IRF8, and BATF3, which enabled them to present antigens as type 1 conventional dendritic cells.

View Article and Find Full Text PDF

MAFF mediates PEITC-induced enhancement of sensitivity to carboplatin in ovarian cancer cell lines via activating ZNF711 transcription in vivo and invitro.

Chem Biol Interact

August 2024

Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China; Department of Clinical Epidemiology, Shengjing Hospital of China Medical University, Shenyang, China; Key Laboratory of Precision Medical Research on Major Chronic Disease, Shengjing Hospital of China Medical University, Shenyang, China; Clinical Research Center, Shengjing Hospital of China Medical University, Shenyang, China. Electronic address:

Enhanced drug resistance poses a significant challenge in treating ovarian cancer (OC). Phenylethyl isothiocyanate (PEITC) is involved in drug resistance in OC, but the mechanism remains unclear. In this study, we investigated the molecular regulatory mechanism of carboplatin sensitivity in OC associated with PEITC, MAF BZIP Transcription Factor F (MAFF), and Zinc finger proteins (ZNF) 711.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!